Navigation Links
STEMCELL Technologies Applauds Feeder-free Derivation of Human Induced Pluripotent Stem Cells
Date:9/15/2009

In a landmark paper, researchers at Stanford University have described a new way to derive human induced pluripotent stem cells (iPSCs) without the use of contaminating mouse feeder cells.

Vancouver, BC (PRWEB) September 15, 2009 -- In a landmark paper, researchers at Stanford University have described a new way to derive human induced pluripotent stem cells (iPSCs) without the use of contaminating mouse feeder cells. Using adipose cells as the starting cell population and mTeSR™1, a defined medium that allows the expansion of human embryonic and induced pluripotent stem cells without the use of feeders, the researchers were able to fully reprogram the cells to the pluripotent state.

iPSCs could potentially become the source of patient specific replacement cells, but methods used to generate these cells to date have relied on the use of mouse feeder cells which make the cells unsuitable for clinical use. "The fact that adipose cells can now be reprogrammed without the use of contaminating feeder cells means we are one step closer to being able to use these cells in the clinic," said Dr. Joseph Wu, Assistant Professor of Medicine and Radiology at Stanford University and senior author on the publication.

"mTeSR™1 is proving to be a very versatile tool for working with iPSCs," said Dr. Clive Glover, Senior Product Manager at STEMCELL Technologies. "Previously, it has been shown that iPSCs can be expanded routinely with mTeSR™1, but this study suggests that mTeSR™1 can be used all the way from initial derivation through to expansion."

mTeSR™1 is a fully defined medium and is the most widely used feeder-independent method for culturing human pluripotent stem cells, with citations in more than 25 publications.

About STEMCELL Technologies
STEMCELL Technologies Inc is a leader in the development and marketing of specialty cell culture media, cell separation products and ancillary reagents for life science research. Driven by science and enabled by close interactions with global leaders in cell biology and medicine, STEMCELL delivers over 900 products to research scientists in more than 70 countries worldwide. To learn more about how STEMCELL helps to make research work, visit www.stemcell.com

Contact
STEMCELL Technologies Inc.
Clive Glover, PhD, Senior Product Manager
604 675 7723    

# # #

Read the full story at http://www.prweb.com/releases/2009/09/prweb2880454.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
2. STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research
3. STEMCELL Technologies Launches Direct Distribution to Singapore
4. STEMCELL Technologies Inc. to Host Stem Cell Training Courses
5. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
6. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
7. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
8. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
9. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
10. Advanced technologies aim to transform the coaching of top athletes
11. Global Med Technologies(R) Extends Its Worldwide Outreach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... new partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) ... for children with autism spectrum disorder (ASD) to see films in an environment ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology: